KMB vs RLAY · P/E 19, rev $8.35B vs rev $3.4M
Kimberly-Clark Corporation (KMB) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the KMB and RLAY stock pages for the full models.
Not investment advice.